US Stock Futures Climb Ahead Of Fed's Beige Book
US stock futures gained in early pre-market trade, ahead of economic data. Data on motor vehicle sales for August will be released today. Data on factory orders for July will be released at 10:00 a.m. ET. The Federal Reserve will release its latest Beige Book report at 2:00 p.m. ET. Futures for the Dow Jones Industrial Average surged 71 points to 17,124.00, while the Standard & Poor's 500 index futures rose 7.90 points to 2,007.70. Futures for the Nasdaq 100 index gained 16.25 points to 4,108.25.
A Peek Into Global Markets
European markets were higher today, with the Spanish Ibex Index rising 1.23%, STOXX Europe 600 Index gaining 0.85%. German DAX 30 index climbed 1.29%, French CAC 40 Index rose 1.21% and London's FTSE 100 Index gained 0.76%. Spain's Markit services PMI climbed to 58.1 in August versus 56.2 in July.
In Asian markets, Japan's Nikkei Stock Average jumped 0.38%, Hong Kong's Hang Seng Index rose 2.30%, China's Shanghai Composite Index surged 1% and India's BSE Sensex jumped 0.45%. China's official nonmanufacturing PMI rose to 54.4 in August versus 54.2 in July, while the HSBC China services PMI climbed to 54.1 in August versus 50.0 in July.
Analysts at Morgan Stanley downgraded American Tower Corporation (REIT) (NYSE: AMT) from Overweight to Equal-weight. The target price for American Tower has been lowered from $101 to $98.
American Tower's shares closed at $98.78 yesterday.
- Medtronic (NYSE: MDT) today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM) R System for transcatheter aortic valve implantation (TAVI). To read the full news, click here.
- The Men's Wearhouse (NYSE: MW) today announced an early termination agreement between its subsidiary, Jos. A. Bank, and Jim's Formal Wear, effective December 31, 2014. To read the full news, click here.
- Toll Brothers (NYSE: TOL) reported better-than-expected third-quarter profit. The Horsham, Pennsylvania-based company posted quarterly net income of $97.7 million, or $0.53 per share, versus a year-ago profit of $46.6 million, or $0.26 per share. To read the full news, click here.
- IRADIMED (NASDAQ: IRMD) today announced that it received a warning letter from the U.S. Food and Drug Administration relating to an inspection of the Company's facility that took place in April 2014. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.